Raising Hope, Advancing Medicines & Leaving No One Behind

What We Have

New Born Screening

Gene Therapy

Medical Support & Equipment

Discover our services

Advancing Newborn Screening for Early Detection

We work closely with leading laboratories to promote newborn screening, ensuring early detection of genetic conditions such as Spinal Muscular Atrophy (SMA). Early diagnosis allows timely intervention, improving the quality of life for affected infants. Through awareness campaigns and collaborations, we aim to make screening more accessible for all newborns in Malaysia.

.

Bringing Gene Therapy to Malaysia

We are at the forefront of introducing cutting-edge treatment for SMA & Thalessemia by partnering with a leading biopharmaceutical company in China. Through this collaboration, we will bring gene therapy to Malaysia via a technology transfer agreement, ensuring local accessibility to this life-changing treatment. Our goal is to make advanced genetic therapies more affordable and available to patients in need.

Bridging the Gap in Medical Equipment Access

We support patients and healthcare providers by facilitating access to essential medical equipment. Whether it’s mobility aids, respiratory support, or specialized hospital supplies, we connect individuals and institutions with the resources they need. Our mission is to ensure that no patient is left behind due to a lack of medical support.

Secure your spot

Interested in learning how our initiatives can benefit you or your organization? Secure your spot for an exclusive consultation to explore:

✔️ Newborn Screening: How early detection can make a difference for your baby.
✔️ Gene Therapy for SMA: The latest advancements and how they will be available in Malaysia.
✔️ Medical Equipment Support: Accessing essential equipment for patients and hospitals.

🔹 Who Should Join?

  • Expecting parents & families with a history of genetic conditions

  • Healthcare professionals & hospitals

  • Organizations looking to collaborate in medical innovation

Our
brand vision

At Raysemedic, we envision a world where medical innovation is accessible to all. Through strategic partnerships and groundbreaking technology, we are transforming healthcare by:

Empowering Early Detection – Championing newborn screening to provide families with timely, life-changing insights.
Bringing Advanced Treatments Closer – Introducing gene therapy for SMA to Malaysia, ensuring that cutting-edge medical solutions are within reach.
Bridging the Gap in Medical Access – Supporting patients and hospitals with essential medical equipment, ensuring no one is left behind.

🚀 "Innovating Today, Saving Lives Tomorrow.".

Follow us on social & latest event

In November 2024, our team visited the Hospital of Kunming, China, to witness the groundbreaking new gene therapy developed by a leading biopharmaceutical company. This visit marked an important step in our mission to bring cutting-edge treatment for Spinal Muscular Atrophy (SMA) to Malaysia through a technology transfer agreement.

By staying at the forefront of medical advancements, Raysemedic is committed to bridging the gap in healthcare access and ensuring that patients in Malaysia benefit from the latest innovations.

đź“… Date: 17th & 18th May 2025
đź“Ť Location: [Event Venue]

Raysemedic is excited to participate in the One Hope Charity Health Carnival! Visit our booth to learn more about:
✔️ Newborn screening and its benefits for early detection.
✔️ Gene therapy for SMA and how it’s coming to Malaysia.
✔️ Medical equipment support for patients and hospitals.

Come speak with our team and discover how we’re making healthcare more accessible. We look forward to seeing you there!

We are honored to be part of the journey of the first Sabahan to participate in a thalassemia clinical trial in China, offering new hope for patients in Malaysia and beyond.

This milestone highlights the potential of advanced gene therapy in transforming the lives of individuals with thalassemia, paving the way for better treatment options in the future. As we continue to advocate for cutting-edge medical advancements, we remain committed to bridging access to innovative therapies for those who need them most.

Stay tuned for updates on this revolutionary treatment and how it could shape the future of thalassemia care in Malaysia.

At Raysemedic, we are proud to be part of a groundbreaking journey in the fight against Spinal Muscular Atrophy (SMA). In collaboration with our partners, we referred the first patient for a gene therapy trial, marking a crucial step in bringing this life-changing treatment to Malaysia.

This moment represents hope, progress, and the future of SMA care, reinforcing our commitment to advancing medical innovation and ensuring access to the latest treatments.

Contact Us

Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!